Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
VERV holding history
Verve Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERV overviewAll 13F holders of VERVFull Q1 2025 holdings
- Shares (Q1 2025)
- 929
- Value
- $4.25K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 929 | $4.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 929 | $5.24K | <0.1% | +108+13.2% | Added | Holders |
| Q3 2024 | 821 | $3.97K | <0.1% | −342−29.4% | Reduced | Holders |
| Q2 2024 | 1,163 | $5.67K | <0.1% | +852+274.0% | Added | Holders |
| Q1 2024 | 311 | $4.13K | <0.1% | −111−26.3% | Reduced | Holders |
| Q4 2023 | 422 | $5.88K | <0.1% | +332+368.9% | Added | Holders |
| Q3 2023 | 90 | $1.19K | <0.1% | +90 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −38−100.0% | Sold out | Holders |
| Q3 2022 | 38 | $1.00K | <0.1% | +38 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −300−100.0% | Sold out | Holders |
| Q2 2021 | 300 | $18.0K | <0.1% | +300 | New | Holders |